BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moctezuma-Velazquez C, Márquez-Guillén E, Torre A. Obesity in the Liver Transplant Setting. Nutrients 2019;11:E2552. [PMID: 31652761 DOI: 10.3390/nu11112552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Cordoza M, Koons B, Perlis ML, Anderson BJ, Diamond JM, Riegel B. Self-reported poor quality of sleep in solid organ transplant: A systematic review. Transplant Rev (Orlando) 2021;35:100650. [PMID: 34534733 DOI: 10.1016/j.trre.2021.100650] [Reference Citation Analysis]
2 Modesto ACF, Silveira EA, Santos ASEADC, Rodrigues APDS, Lima DM, Provin MP, Amaral RG. Prevalence of Adverse Drug Events in Severely Obese Adults and Associated Factors: Clinical Trial Baseline Results. Sci Pharm 2020;88:41. [DOI: 10.3390/scipharm88040041] [Reference Citation Analysis]
3 Van J, Aloman C, Reau N. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. Am J Gastroenterol 2021;116:2089-97. [PMID: 34193797 DOI: 10.14309/ajg.0000000000001349] [Reference Citation Analysis]
4 Yuan F, Latif MA, Shafaat O, Prologo JD, Hill JO, Gudzune KA, Marrone AK, Kraitchman DL, Rogers AM, Khaitan L, Oklu R, Pereira K, Steele K, White SB, Weiss CR. Interventional Radiology Obesity Therapeutics: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol 2021;32:1388.e1-1388.e14. [PMID: 34462083 DOI: 10.1016/j.jvir.2021.05.029] [Reference Citation Analysis]
5 Hartl L, Elias J, Prager G, Reiberger T, Unger LW. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. World J Gastroenterol 2021; 27(19): 2281-2298 [PMID: 34040322 DOI: 10.3748/wjg.v27.i19.2281] [Reference Citation Analysis]
6 Chauhan K, Khan A, Chowdhury S, Ross HM, Parra NS, Halegoua-demarzio D. A Comprehensive Review on the Risk of Metabolic Syndrome and Cardiovascular Disease after Liver Transplantation. Livers 2022;2:85-96. [DOI: 10.3390/livers2020006] [Reference Citation Analysis]
7 Douglas SJ, Remily EA, Sax OC, Pervaiz SS, Mohamed NS, Kelemen MN, Delanois RE, Johnson AJ. Primary total hip arthroplasty complications and costs in liver transplant recipients: a matched analysis using a national database. Hip Int 2021;:11207000211037225. [PMID: 34748455 DOI: 10.1177/11207000211037225] [Reference Citation Analysis]
8 Czarnecka K, Czarnecka P, Tronina O, Bączkowska T, Durlik M. Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. Immun Inflamm Dis 2021. [PMID: 34598315 DOI: 10.1002/iid3.538] [Reference Citation Analysis]
9 Cheng YL, Elli EF. Outcomes of Bariatric Surgery After Solid Organ Transplantation. OBES SURG 2020;30:4899-904. [DOI: 10.1007/s11695-020-05013-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 de Barros F, Cardoso Faleiro Uba PH. Liver transplantation and bariatric surgery: a new surgical reality: a systematic review of the best time for bariatric surgery. Updates Surg 2021. [PMID: 34118015 DOI: 10.1007/s13304-021-01106-3] [Reference Citation Analysis]